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Abstract
Background: Merlin, the product of the Neurofibromatosis type 2 (NF2) tumor suppressor gene, belongs to the ezrin-
radixin-moesin (ERM) subgroup of the protein 4.1 superfamily, which links cell surface glycoproteins to the actin
cytoskeleton. While merlin's functional activity has been examined in mammalian and Drosophila  models, little is
understood about its evolution, diversity, and overall distribution among different taxa.
Results: By combining bioinformatic and phylogenetic approaches, we demonstrate that merlin homologs are present
across a wide range of metazoan lineages. While the phylogenetic tree shows a monophyletic origin of the ERM family,
the origin of the merlin proteins is robustly separated from that of the ERM proteins. The derivation of merlin is thought
to be in early metazoa. We have also observed the expansion of the ERM-like proteins within the vertebrate clade, which
occurred after its separation from Urochordata (Ciona intestinalis). Amino acid sequence alignment reveals the absence
of an actin-binding site in the C-terminal region of all merlin proteins from various species but the presence of a
conserved internal binding site in the N-terminal domain of the merlin and ERM proteins. In addition, a more conserved
pattern of amino acid residues is found in the region containing the so-called "Blue Box," although some amino acid
substitutions in this region exist in the merlin sequences of worms, fish, and Ciona. Examination of sequence variability
at functionally significant sites, including the serine-518 residue, the phosphorylation of which modulates merlin's intra-
molecular association and function as a tumor suppressor, identifies several potentially important sites that are conserved
among all merlin proteins but divergent in the ERM proteins. Secondary structure prediction reveals the presence of a
conserved α-helical domain in the central to C-terminal region of the merlin proteins of various species. The conserved
residues and structures identified correspond to the important sites highlighted by the available crystal structures of the
merlin and ERM proteins. Furthermore, analysis of the merlin gene structures from various organisms reveals the
increase of gene length during evolution due to the expansion of introns; however, a reduction of intron number and
length appears to occur in the merlin gene of the insect group.
Conclusion: Our results demonstrate a monophyletic origin of the merlin proteins with their root in the early metazoa.
The overall similarity among the primary and secondary structures of all merlin proteins and the conservation of several
functionally important residues suggest a universal role for merlin in a wide range of metazoa.
Published: 02 December 2005
BMC Evolutionary Biology 2005, 5:69 doi:10.1186/1471-2148-5-69
Received: 18 March 2005
Accepted: 02 December 2005
This article is available from: http://www.biomedcentral.com/1471-2148/5/69
© 2005 Golovnina et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Evolutionary Biology 2005, 5:69 http://www.biomedcentral.com/1471-2148/5/69
Page 2 of 18
(page number not for citation purposes)
Background
The advancement in genome sequencing projects, the
accumulation of knowledge in bioinformatics, and the
molecular genetic analysis of genes and their functions in
a variety of model organisms provides us with an unprec-
edented opportunity to identify novel genes based on
sequences related to characterized genes [1]. This process
is conducted using pairwise sequence comparison with
the understanding that genes form families wherein
related sequences likely share similar functions. Although
initial identification of new genes may not yield a clear
indication of their respective functions, studies on their
evolution may allow validation of their sequence identity
and provide information on their putative functional
characteristics. For genes evolved from duplication and/or
adapted to different evolutionary niches during specia-
tion, detailed sequence comparison can provide addi-
tional information regarding their biological and
biochemical characteristics [2].
Neurofibromatosis type 2 (NF2) is a highly penetrant,
autosomal dominant disorder, whose hallmark is the
development of bilateral vestibular schwannomas [3,4].
The tumor suppressor gene associated with NF2 has been
identified and termed the neurofibromatosis type 2 gene
(NF2) [5,6]. The NF2 gene encodes a protein named mer-
lin, for moesin-ezrin-radixin like protein, or schwan-
nomin, a word derived from schwannoma, the most
prevalent tumor seen in NF2. For simplicity, we refer to
the NF2 gene product as merlin hereafter.
Merlin shares sequence similarity with the ezrin, radixin,
and moesin (ERM) proteins, which belong to the protein
4.1 superfamily of cytoskeleton-associated proteins that
link cell surface glycoproteins to the actin cytoskeleton
[7,8]. Like ERM proteins, merlin consists of three pre-
dicted structural domains [5,6,9]. The N-terminal
domain, termed the FERM (F for 4.1) domain, is highly
conserved among all members of the ERM family and is
important for interactions with cell surface glycoproteins,
including CD44 and intercellular adhesion molecules
[10-13]. Crystal structure analysis shows that the tertiary
structure of the FERM domain of merlin closely resembles
those of the FERM domain of moesin and radixin [14-18].
The FERM domain of merlin exists as a clover-shaped
molecule consisting of three structural subdomains A, B,
and C, which are homologous to lobes F1, F2, and F3 in
moesin and radixin. Subdomain A, composed of residues
20–100, possesses a ubiquitin-like fold. Subdomain B,
consisting of residues 101–215, folds itself into a topol-
ogy like that of the acetyl-CoA-binding protein. Sub-
domain C, containing residues 216–313, adopts the
pleckstrin homology/phosphotyrosine-binding fold
found in a broad range of signaling molecules [14-16].
The second half of merlin contains a predicted α-helix
domain, which is also present in the ERM proteins [19].
Although the unique C-terminus of merlin lacks the con-
ventional actin-binding domain found in the ERM pro-
teins [20,21], merlin can directly bind actin using the
residues at the N-terminal domain and indirectly through
its association with βII-spectrin or fodrin [22-24].
The merlin and ERM proteins are thought to be key regu-
lators of interactions between the actin cytoskeleton and
the plasma membrane in polarized cells. They act as
important members of signal transduction pathways that
control cell growth and participate in the sorting of mem-
brane proteins during exocytic traffic [25,26]. However,
unlike the ERM proteins, merlin has a distinct function as
a tumor suppressor [27]. Growth suppression by merlin is
dependent on its ability to form intramolecular associa-
tions [28,29]. In this regard, merlin exists in an "open"
(inactive form) or "closed" (active growth-suppressive
form) conformation that is regulated by phosphorylation
[30-35].
While previous studies have focused primarily on the
functional analysis of merlin, limited information is avail-
able about its overall distribution across eukaryotes and
its evolution. A phylogenetic study indicates that the
FERM domains of ERM homologs from sea urchins,
Caenorhabditis elegans, Drosophila melanogaster, and verte-
brates share 74–82% amino acid identity and have about
60% identity with those of merlin [25,36-42]. These levels
of identity are exceptionally high, suggesting that the pro-
tein structures of the merlin and ERM proteins from these
species may be well-conserved. The most divergent ERM
proteins are found in tapeworms and schistosomes [36-
39]. The FERM domains of these parasite proteins share
only 44–58% similarity to their vertebrate homologs. The
high degree of structural conservation among these pro-
teins points to possible similarities or functional redun-
dancies. Intriguingly, no FERM domain-encoding genes
have been identified in the genome of the yeast Saccharo-
myces cerevisiae, implying that FERM domains evolved in
response to multicellularity, rather than as a cytoskeletal
component [25].
The goal of the present study was to expand our under-
standing of the taxonomic diversity of merlin and the phy-
logenetic relationships using experimentally annotated
and predicted sequences. By the integration of the BLAST-
based analysis using the available partial and whole
genome sequences with phylogeny reconstruction, we
have generated an evolutionary tree for the entire ERM-
family members from various taxa and identified some
interesting details about their phylogenetic origin. In
addition, we compared sequence variability at function-
ally significant sites, including the major phosphorylation
site of merlin, predicted the secondary structure of theB
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Table 1: The list of the predicted and experimentally annotated merlin and ERM proteins included in this study.
Species Proteins UniProtKB/Swiss-
Prot Identifiers
GenBank 
Accession No.
Entries from Genome 
Sequencing Projects
Related Resources
Homo sapiens merlin (NF2) P35240 AAA36212 http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=gmd=Retrieve&dopt=Overview&list_uids=9558
ezrin P15311 CAA35893
radixin P35241 AAA36541
moesin P26038 AAA36322
Pan troglodytes similar to NF2 XP_515061 http://www.hgsc.bcm.tmc.edu/projects/chimpanzee/
Papio anubis merlin P59750 AAO23133 http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=gmd=Retrieve&dopt=Overview&list_uids=12965
Bos taurus ezrin P31976 AAA30510 http://www.hgsc.bcm.tmc.edu/projects/bovine/
Sus scrofa radixin P26044 AAB02865 http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?spec
moesin P26042 AAB02864
Canis familiaris similar to NF2 XP_534729 http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?spec
Oryctolagus cuniculus ezrin Q8HZQ5 AAN06818 http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=gmd=Retrieve&dopt=Overview&list_uids=12818
Mus musculus ezrin P26040 CAA43086 http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?spec
radixin P26043 CAA43087
merlin P46662 CAA52737
Rattus norvegicus ezrin P31977 AAR91694 http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?spec
NF2 XP_341249
Gallus gallus ezrin Q9YGW6 BAA75497 http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?spec
radixin Q9PU45 CAB59977
merlin NP_989828
Xenopus laevis unknown AAH77822 http://www.xenbase.org/
protein
Danio rerio nf2a Q6Q413 AAS66973 http://www.ensembl.org/Danio_rerio/
moesin Q503E6 AAH95359
Fugu rubripes radixin FRUP00000132603 http://genome.jgi-psf.org/
moesin FRUP00000156313
merlin FRUP00000136298
Tetraodon nigroviridis unnamed CAG08868 http://www.ensembl.org/Tetraodon_nigroviridis/
protein 1 CAG08250
unnamedB
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protein 2
Ciona intestinalis erm-like ci0100149701 http://genome.jgi-psf.org/
merlin-like ci0100130636
Ciona savignyi merlin-like paired_scaffold_109 http://www.broad.mit.edu/ftp/
Biomphalaria glabrata erm-like AAK61353 http://biology.unm.edu/biomphalaria-genome/
Lytechinus variegates moesin P52962 AAC46514 http://www.hgsc.bcm.tmc.edu/projects/seaurchin/
Apis mellifera similar to 
schwannomin
XP_392673 http://racerx00.tamu.edu/PHP/bee_search.php
Drosophila melanogaster merlin Q24564 AAB08449 http://fbserver.gen.cam.ac.uk:7081/
moesin P46150 AAB48934
Drosophila yakuba merlin-like predicted in this work http://genome.wustl.edu/blast/client.pl
Anopheles gambiae merlin-like 
fragment
EAA07087 http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?spec
Caenorhabditis elegans erm1a P91015 AAB37643 http://www.wormbase.org/
erm1b P91016 AAB37642
nfm 1a Q20307 AAA19073
nfm 1b Q95QG5 AAK68385
Caenorhabditis briggsae erm-like BP:CBP03133 http://www.wormbase.org/
nfm1 BP:CBP05025
Caenorhabditis remanie merlin-like predicted in this work http://genome.wustl.edu/blast/client.pl
erm-like
Brugia malayi merlin-like 316.m00022 http://www.tigr.org/tdb/e2k1/bma1/
Schistosoma japonicum JF2 AAB49033 http://www.nhm.ac.uk/hosted_sites/schisto/
Taenia saginata myosin-like Q94815 CAA65728 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=protein
Echinococcus multilocularis EM10 A45620 http://www.sanger.ac.uk/Projects/Echinococcus/
Echinococcus granulosus EG10 Q24796 CAA82625
Phanerochaete chrysosporium --- http://genome.jgi-psf.org/whiterot1/whiterot1.home
Aspergillus flavus --- http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?spec
Arabidopsis thaliana --- http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?spec
Oryza sativa --- http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?spec
Trypanosoma brucei --- http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?spec
Cryptosporidium parvum --- http://www.tigr.org/tigr-scripts/tgi/T_index.cgi?species=c_parvum
Table 1: The list of the predicted and experimentally annotated merlin and ERM proteins included in this study. (Continued)BMC Evolutionary Biology 2005, 5:69 http://www.biomedcentral.com/1471-2148/5/69
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The neighbor-joining tree of the ERM family Figure 1
The neighbor-joining tree of the ERM family. The diagram illustrates the basic resolution of the ERM-family members 
into two major clades, merlin and ERM. Bootstrap support values are shown above each node. Shaded boxes denote different 
subgroups of the ERM clade in vertebrates, which appeared after the expansion of the ERM-like ancestor. The Tetraodon nigro-
viridis "unnamed protein 1 and 2" sequences (GenBank Accession No. CAG08868 and CAG08250, respectively) and the Xeno-
pus laevis "unknown protein" sequence (GenBank Accession No. AAH77822) were grouped based on their similarity to the 
merlin or ERM sequences.BMC Evolutionary Biology 2005, 5:69 http://www.biomedcentral.com/1471-2148/5/69
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merlin proteins of various species, and examined the
exon-intron structural evolution of the NF2 gene.
Results and Discussion
BLAST identification of merlin sequences
To identify putative merlin and ERM sequences in a wide
range of eukaryotes, we performed BLAST analysis of 15
available genome databases. By searching through all
annotated proteins and genome sequences, we identified
50 sequences from 30 species. Table 1 summarizes the full
list of the predicted and annotated merlin and ERM pro-
teins identified, and their GenBank and available Uni-
ProtKB/Swiss-Prot accession numbers and related
resources. No merlin-like sequences were found in the
genomes of fungi, plants, and protozoa. While the
sequencing projects of the hard ticks are still ongoing at
The Institute for Genomic Research (TIGR), amino acid
sequences deduced from partial cDNAs of salivary glands,
which share a similarity with the FERM domain of merlin,
have been noted from Rhipicephalus appendiculatus [43],
Amblyomma variegatum [44], and Boophilus microplus [45].
Assembly of predicted merlin sequences from whole 
genome shotgun
To date, the genomes of Caenorhabditis remanei and Dro-
sophila yakuba are represented by a set of contigs [46].
When contigs are ordered, oriented, and positioned with
respect to each other by mate-pair reads, they are
described as a scaffold. Scaffolds are the main product of
the Whole Genome Shotgun strategy and can be assigned
to chromosomes using chromosome-specific markers.
Although the extensive scaffolds for the genomes of
Caenorhabditis remanei and Drosophila yakuba are not cur-
rently available, we were able to assemble predictive pro-
tein sequences, which most resemble the merlin sequence
of the closely-related organism, Caenorhabditis elegans or
Drosophila melanogaster, respectively, using TBLASTN
search across the available sets of contigs. In the Drosophila
yakuba  contig 49.37, we identified a predicted merlin
sequence, which is nearly identical to that of the Dro-
sophila melanogaster protein with the exception of three
positions at the C-terminus, two substitutions at
Glu468→Asp and Asn579→Ser and an insertion of Lys at
position 575. Also, we found three Caenorhabditis remanei
contigs, 564.6, 2151.1, and 2151.2, which contained mer-
lin-like sequences with similarity, ranging from 81% to
100%, to its Caenorhabditis elegans counterpart. It should
be noted that the deduced amino acid sequences were
assembled manually, and in some cases, only partial or
approximate amino acid sequences could be obtained.
Nevertheless, they were useful for the identification of the
definite gene in the respective genome and were valuable
for the following phylogenetic reconstruction in order to
validate the functional relationship and evolution of the
definite gene.
Construction of a phylogenetic tree for the ERM family of 
proteins
To understand the origin and evolution of merlin, we con-
ducted a phylogenetic analysis of the 50 proteins of the
ERM family, which were identified from 30 different taxa
(Table 1) using the neighbor-joining method [47,48]
combined with the molecular evolutionary genetics anal-
ysis program MEGA2 [49]. Three protein 4.1 sequences
from humans, mice, and zebrafish, respectively, were used
as an outgroup. By comparing the bootstrap support val-
ues, which denote the number of times a grouping occurs
out of 1,000 random samples from the alignment, we
constructed a phylogenetic tree for the ERM family of pro-
teins (Figure 1). Based on this phylogenetic analysis, the
entire ERM family can be subdivided into the ERM clade
and the merlin clade. While both clades show a strongly
supported monophyletic origin, the merlin clade can be
robustly defined and separated from the ERM clade (the
bootstrap support value = 100). We identified a total of 22
sequences for the merlin clade and 28 sequences for the
ERM clade. The topology of the phylogenetic tree within
the merlin clade appears to agree with the general concept
of evolutionary history of speciation.
The merlin clade can be further divided into three groups
according to the order of derivation: worms, insects, and
Chordata, with the earliest separated genus, Ciona, in the
last taxonomic unit (Figure 1). The predicted merlin-like
sequence from Caenorhabditis remanei branched from that
of Caenorhabditis elegans, and similarly, Drosophila yakuba
diverged from its Drosophila melanogaster counterpart.
Both the "unnamed protein 1" of Tetraodon nigroviridis
and the "unknown protein" of Xenopus laevis from the
GenBank database are clustered in the Chordata merlin-
like group with high bootstrap probabilities (Figure 1),
which confirms their identity as merlin homologs. The
protein fragment from Anopheles gambiae, which bears a
sequence similarity to merlin, is grouped together with
the Apis mellifera merlin-like protein by a bootstrap sup-
port value of 100.
Although the ERM-like proteins have been identified in
Taenia saginata, Schistosoma japonicum, Echinococcus granu-
losus, and Echinococcus multilocularis [36-39], we did not
find any merlin-like sequences in the genomes of these
species. The lack of merlin-like sequences in these parasite
genomes may be due to incomplete genome sequences in
the database; however, this explanation is unlikely
because the merlin-like sequence was also not observed in
the genome of Schistosoma mansoni, which has been rigor-
ously studied [50]. Another possibility is that the absence
of merlin-like sequences in these organisms may reflect
their adaptation to a parasitic lifestyle and the reduction
of various organ systems. Alternatively, the merlin protein
may emerge later during evolution. Similarly, no merlin-BMC Evolutionary Biology 2005, 5:69 http://www.biomedcentral.com/1471-2148/5/69
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like sequence was found in the complete genomes of pro-
tozoa, fungi, and plants. Based on these results, we sup-
pose that the derivation of merlin occurred in the early
metazoa after its separation from flatworms.
As illustrated in the ERM clade in Figure 1, the ERM-like
proteins found in parasites can be grouped together but
form a separate branch from the rest of ERM proteins.
Based on the phylogenetic analysis, the clustering of the
"unnamed protein 2" of Tetraodon nigroviridis with the
Fugu rubripes radixin protein defines it as a radixin-like
protein. It should be noted that the two predicted ERM
proteins, erm1a and erm1b of Caenorhabditis elegans [51],
may represent different transcript variants of the same
gene (also see below).
Furthermore, we have observed the evident expansion of
the ERM-like ancestor in vertebrates (Figure 1). Since the
ERM homolog of Ciona emerged prior to the vertebrate
clade, it appears that the first duplication of the vertebrate
ERM sequence occurred after its divergence from Ciona.
Subsequent expansion within this sub-family has led to
the present existence of three related groups of proteins,
ezrin, radixin and moesin; among which, the ezrin group
is the most ancient. Such an expanded complement may
only be common to the ERM proteins of vertebrates
because other metazoa have only one predicted ERM-like
homolog [52-56]. Curiously, the increasing number of
ERM members that occurred within the vertebrate clade
paralleled the evolutionary complexity of the organism. It
will be important to understand how these proteins
Sequence alignments of functionally important sites in the merlin and ERM proteins of various species Figure 2
Sequence alignments of functionally important sites in the merlin and ERM proteins of various species. Com-
parison of the C-terminal region including the actin-binding site and two other predicted significant residues. Databank 
resources for the ERM-family proteins listed in Table 1 were used in the analysis, and only typical representatives from each 
group are displayed.
••
546
H. sapiens merlin
C. familiaris similar to nf2
M. musculus merlin
G. gallus merlin-like
X. laevis unknown protein
D. rerio nf2a
F. rubripes merlin
C. intestinalis merlin-like
C. savignyi merlin-like
A. gambiae fragment of merlin
A. mellifera similar to schwannomin
D. melanogaster merlin
C. elegans nfm 1a
C. briggsae merlin-like
B. malayi merlin-like
H. sapiens ezrin
B. taurus ezrin
G. gallus ezrin
H. sapiens radixin
G. gallus radixin
T. nigroviridis unnamed protein 2
H. sapiens moesin
F. rubripes moesin
C. intestinalis erm-like
B. glabrata erm-like
L. variegates moesin
C. elegans erm-like 1a
C. briggsae erm-like
D. melanogaster moesin
T. saginata myosin-like
E. multilocularis EM10
Actin-binding site
EIEALKLKERET----------ALDILHNENSDRGG--SSKHNTIKKLTLQSAKSRVAFFEEL---- EIEALKLKERET----------ALDILHNENSDRGG--SSKHNTIKKLTLQSAKSRVAFFEEL----
EIEALKLKERET----------ALDILHNENSDRGGT-SSKHNTIKKLTLQSAKSRVAFFEEL---- EIEALKLKERET----------ALDILHNENSDRGGT-SSKHNTIKKLTLQSAKSRVAFFEEL----
EIEALKLKERET----------ALDVLHSESSDRGGP-SSKHNTIKKLTLQSAKSRVAFFEEL---- EIEALKLKERET----------ALDVLHSESSDRGGP-SSKHNTIKKLTLQSAKSRVAFFEEL----
EIEALKLKERET----------ALDILHNENASRGN---SKHNTIKKVSEGSSLYLA---------- EIEALKLKERET----------ALDILHNENASRGN---SKHNTIKKVSEGSSLYLA----------
EIESLKLKERES----------AMDIMH----ENAG---SKQNTIKKARRAVCI------------- EIESLKLKERES----------AMDIMH----ENAG---SKQNTIKKARRAVCI-------------
EIESLKLEEQQQ----------AGVYNLRSYAEPPFIPPSNRNSAYMAQMAFYEE------------ EIESLKLEEQQQ----------AGVYNLRSYAEPPFIPPSNRNSAYMAQMAFYEE------------
EIESLKLKERET----------PLDIIHNQNTEQGT---SKQSNFKK-------------------- EIESLKLKERET----------PLDIIHNQNTEQGT---SKQSNFKK--------------------
EIEVLKVDESMT----------GFDQKQDS----NQ-----PHTHEISTFQGHKETPQYYDGL---- EIEVLKVDESMT----------GFDQKQDS----NQ-----PHTHEISTFQGHKETPQYYDGL----
EIEVLKVDENTG----------PFNQKPDP----SQ-----SVSHDATTFQSHNE------------   EIEVLKVDENTG----------PFNQKPDP----SQ-----SVSHDATTFQSHNE------------  
EIEQLKIGENQC----------PLDDINAEQLRLGE---TKYSTLKKVKSGSTKARVAFFEEL---- EIEQLKIGENQC----------PLDDINAEQLRLGE---TKYSTLKKVKSGSTKARVAFFEEL----
EIEVMKVGEKQC----------ELDQLHEEQVRLGE---NKYSTLKKVKSGSTKARVAFFEEL---- EIEVMKVGEKQC----------ELDQLHEEQVRLGE---NKYSTLKKVKSGSTKARVAFFEEL----
EIAPHKIEENQS----------NLDILSEAQIKAGE---NKYSTLKKLKSGSTKARVAFFEEL---- EIAPHKIEENQS----------NLDILSEAQIKAGE---NKYSTLKKLKSGSTKARVAFFEEL----
DIDGLKRDGNVQ-NG----QHREHDAVHAQNVAHGFDKFTTMRMSMRGTPRQR--AQAFDGM----- DIDGLKRDGNVQ-NG----QHREHDAVHAQNVAHGFDKFTTMRMSMRGTPRQR--AQAFDGM-----
DIDGLKRDENMT-----IQQHREHDAIHAQNVAQGFDKFTTMRMVRQG------------------- DIDGLKRDENMT-----IQQHREHDAIHAQNVAQGFDKFTTMRMVRQG-------------------
EIESLKVVDRQS----------EHDRIHAANLQMGI---DKYSTLR--------------------- EIESLKVVDRQS----------EHDRIHAANLQMGI---DKYSTLR---------------------
ELSQARDENKR----------THNDIIHNENMRQGR---DKYKTLRQIRQGNTKQRIDEFEAL---- ELSQARDENKR----------THNDIIHNENMRQGR---DKYKTLRQIRQGNTKQRIDEFEAL----
ELSQARDENKR----------THNDIIHNENMRQGR---DKYKTLRQIRQGNTKQRIDEFEAM---- ELSQARDENKR----------THNDIIHNENMRQGR---DKYKTLRQIRQGNTKQRIDEFEAM----
ELAQARDEDKR----------TQNDIIHSENVRQGR---DKYKTLRQIRQGNTKQRIDEFEAM---- ELAQARDEDKR----------TQNDIIHSENVRQGR---DKYKTLRQIRQGNTKQRIDEFEAM----
ELAQARDETKK----------TQNDVLHAENVKAGR---DKYKTLRQIRQGNTKQRIDEFEAM---- ELAQARDETKK----------TQNDVLHAENVKAGR---DKYKTLRQIRQGNTKQRIDEFEAM----
ELAQARDETKK----------TQNDVLHAENVKAGR---GKYKTLRQIRQGNTKQRIDEFEAM---- ELAQARDETKK----------TQNDVLHAENVKAGR---GKYKTLRQIRQGNTKQRIDEFEAM----
GLGSELGVGGS----------SRRHQEDAERHAARR---ERQGRKRQVQNAASDPPGQHQAAHRRVR GLGSELGVGGS----------SRRHQEDAERHAARR---ERQGRKRQVQNAASDPPGQHQAAHRRVR
ELANARDESKK----------TANDMLHAENMRLGR---DKYKTLRQIRQGNTKQRIDEFESM---- ELANARDESKK----------TANDMLHAENMRLGR---DKYKTLRQIRQGNTKQRIDEFESM----
ELANARDESKK----------TVNDILHAENVRAGR---DKYKTLRQIRSGNTKQRIDEFECM---- ELANARDESKK----------TVNDILHAENVRAGR---DKYKTLRQIRSGNTKQRIDEFECM----
QLSQLRDNNVTS---------TQMDILHNENVKAGR---DKYKTLKQIRSGNTKHRIDEFECL---- QLSQLRDNNVTS---------TQMDILHNENVKAGR---DKYKTLKQIRSGNTKHRIDEFECL----
DLDAEKTKQNA------------IDLLHQENMRQGR---DKYKTLKQIRQGNTKQRVDEFESM---- DLDAEKTKQNA------------IDLLHQENMRQGR---DKYKTLKQIRQGNTKQRVDEFESM----
ELQAMKDESKGE---------DRYDKIHQENIRAGR---DKYQTLRNIRSGNTRQRIDTFENI---- ELQAMKDESKGE---------DRYDKIHQENIRAGR---DKYQTLRNIRSGNTRQRIDTFENI----
ELDSVKDQNAV----------TDYDVLHMENKKAGR---DKYKTLRQIRGGNTKRRIDQYENM---- ELDSVKDQNAV----------TDYDVLHMENKKAGR---DKYKTLRQIRGGNTKRRIDQYENM----
ELDSVKDQNAV----------TDYDVLHMENKKAGR---DKYKTLRQIRGGNTKRRIDQYENM---- ELDSVKDQNAV----------TDYDVLHMENKKAGR---DKYKTLRQIRGGNTKRRIDQYENM----
DLAQSRDETKET----------ANDKIHRENVRQGR---DKYKTLREIRKGNTKRRVDQFENM---- DLAQSRDETKET----------ANDKIHRENVRQGR---DKYKTLREIRKGNTKRRVDQFENM----
ELSSTRDPSKM----------RDIDRHHEYNVREGN---DKYKTLRNIRKGNTMCRVEQFESM---- ELSSTRDPSKM----------RDIDRHHEYNVREGN---DKYKTLRNIRKGNTMCRVEQFESM----
ELSSTRDQSKM----------RDIDRRHEYNVREGN---DKYKTLRNIRKGNTMCRVEQFESM---- ELSSTRDQSKM----------RDIDRRHEYNVREGN---DKYKTLRNIRKGNTMCRVEQFESM----
595
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589
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670
627
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654
635
438
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evolved and how their functions coordinated because of
the important and diverse functions of ERM proteins
[8,25,26].
Evolution of the functionally important residues in merlin
Although initial identification of proteins via sequence
similarities does not yield a clear indication of their
respective functions, analysis of specific conserved regions
and residues may provide important information regard-
ing their putative functional characteristics. We conducted
pairwise sequence comparison among all obtained merlin
and ERM sequences, and identified several regions of
interest. The results of the entire sequence alignment are
provided in the Additional File 1 and are summarized in
Alignment of the N-terminal domain, containing the Blue Box and the amino acid residue 204, conserved among the merlin  proteins but divergent in the ERM proteins Figure 3
Alignment of the N-terminal domain, containing the Blue Box and the amino acid residue 204, conserved among the merlin 
proteins but divergent in the ERM proteins.
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D. melanogaster merlin
C. elegans nfm-1a
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H. sapiens radixin
G. gallus radixin
T. nigroviridis unnamed protein 2
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F. rubripes moesin
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E. multilocularis EM10
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Figures 2, 3, and 4. Previously, the conservation of the N-
terminal FERM domain among human ERM proteins and
their functional importance were described [10-13]. In
our alignment, we showed that this conservation
extended to the merlin and ERM proteins of various spe-
cies for which sequences were available to date. These data
suggest a universal role for the presence of the FERM
domain during evolution and further imply an existence
of certain evolutionary constraints on the changes of their
amino acid residues.
Although merlin lacks the C-terminal actin-binding site
found in ERM proteins [7,20,21,57], it can directly inter-
act with the actin cytoskeleton [22,58] or indirectly bind
via the actin-binding protein βII spectrin/fodrin [23,24].
Sequence alignment showed extensive amino acid varia-
bility in the C-terminal region of the merlin proteins of
various species, while a noncontiguous stretch of 25
amino acid residues, including the well-defined actin-
binding site, was reliably aligned among all predicted
ERM proteins with the exception of the "unnamed protein
2" of Tetraodon nigroviridis (Figure 2). According to the
phylogenetic tree, the "unnamed protein 2" of Tetraodon
nigroviridis is classified in the radixin group (Figure 1), and
its sequence visibly differs from other radixin proteins
only at the C-terminus. The reason for this sequence vari-
ability is presently unknown. It may be due to an inaccu-
racy in sequence assembly from the scaffold. Alternatively,
the "unnamed 2 protein" may possess a unique character-
istic and will be of considerable interest for functional
comparison with other radixin proteins.
Sequence variability at the C-terminal domain of the mer-
lin proteins of various species appears to be high, while
some conservation can be found within separate taxo-
nomic groups such as vertebrates, insects, and worms
(Figure 2 and Additional File 1). A part of the C-terminal
region is absent in Fugu rubripes, Danio rerio, C. briggsae,
and Brugia malayi. This may be due to partial assembly of
the protein sequences, as all of them were predicted by
bioinformatics using the available genomes and cDNA
sequences. Alternatively, the lack of conservation in the C-
terminal region of merlin in these species may imply that
this region does not share the same function. In the
remaining organisms, the C-terminal amino acid residues
have a specific charge distribution, in spite of decreased
hydrophilicity, when compared with the C-terminal part
of moesin [15]; however, they likely form structures simi-
lar to the B, C, and D helices found in moesin.
Unlike ERM proteins, two regions (residues 1–27 and
280–323) in the N-terminal half of merlin have been
mapped that are sufficient for binding to F-actin [59,60].
The first 17 amino acids in the N-terminus of human mer-
lin are present in the merlin proteins of various species
but not in any ERM proteins (see Additional File 1). The
merlin proteins of higher vertebrates contain these resi-
dues, eight of which are absent in the merlin proteins of
other organisms. Crystal structure analysis suggests that
the structure of these extreme N-terminal residues of mer-
lin is disordered in solution but likely becomes ordered as
merlin binds to some effector targets [17]. Our sequence
alignment indicates that the conservation in the extreme
Sequence alignments reveal conservation of several functionally important residues, including the major phosphorylation site of  the merlin group Figure 4
Sequence alignments reveal conservation of several functionally important residues, including the major phosphorylation site of 
the merlin group.
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N-terminus of merlin extends to the first 27 residues. The
distribution of specific positively-charged residues also
appears to be conserved in this N-terminal portion of the
merlin proteins of lower vertebrates and insects. These
results suggest that the first 27 amino acids of merlin serve
as a common protein-binding motif. It is noteworthy that
a similar sequence can be found in the ERM-like protein
of Ciona; however, the N-terminal region of the Ciona pro-
tein contains ten positively-charged, basic amino acids,
which may affect the binding to actin and/or other pro-
teins (Additional File 1).
The internal actin-binding site, containing residues 280–
323 in the N-terminal half of merlin, was found to be
highly conserved among all merlin and ERM proteins ana-
lyzed, particularly the last 30 amino acid residues (Addi-
tional File 1). This region contains an extended helix at
the beginning of the α-helical domain and its importance
is supported by the identification of several disease-caus-
ing mutations (S315F, L316F, L316W, Q324L), which
were predicted to destabilize the α-helical segment and
disrupt its hydrogen bonding with subdomain A [16-18].
In addition, these residues have been shown to associate
with F-actin in moesin [61,62] and to contribute to the
ICAM-2-binding site in radixin [14].
Previously, LaJeunesse et al. [63] identified seven func-
tionally important amino acid residues
(170YQMTPEM177) in the N-terminal domain of Dro-
sophila merlin, called the "Blue Box." These seven amino
acids are identical between the human and Drosophila
merlin proteins but differ from the ERM proteins.
Sequence comparison revealed a more conserved pattern
of the Blue Box; all seven amino acid residues of the Blue
Box were found to be identical in the merlin sequences
from vertebrates, fruit flies, and honeybees (Figure 3);
however, several amino acid substitutions were found in
the Blue Box of worms, fish, and Ciona. The most interest-
ing substitutions were found in the merlin-like protein of
Caenorhabditis from 174ThrProGlu176 to 174SerAlaAsp176. It
is noteworthy that the methionine residue at position 177
in the Blue Box is conserved among all merlin proteins
but not in the ERM proteins. These results further corrob-
orate the functional importance of the seven amino acids
in the Blue Box [63].
According to the crystal structure of the FERM domain in
human merlin, the Blue Box residues are located in helix
α3B of subdomain B [18] and form a defined area that is
located on the surface of the protein [17]. Intriguingly, the
three-dimensional conformation of merlin's Blue Box
region is similar to that of the equivalent region in radixin
[18], suggesting that regions in addition to the Blue Box
are required for merlin to function as a tumor suppressor.
Note that regions closely adjacent to the Blue Box-equiva-
lent residues in human ERM proteins have been shown to
participate in the N-terminal to C-terminal intramolecular
interaction and ligand-binding, enabling increased
mobility and structural changes in the activated FERM
domain [14-16,64]. In light of the functional importance
of the Blue Box in Drosophila merlin, its sequence conser-
vation during evolution, and its location on the surface of
merlin, the Blue Box probably participates in specific pro-
tein-protein interactions and contributes to other activi-
ties of merlin.
As in ERM proteins, phosphorylation affects the subcellu-
lar localization and intra- and inter-molecular associa-
tions of merlin [13,30-32]. In addition, it modulates the
ability of merlin to suppress cell growth [34,35]. Two
phosphorylation sites have been mapped to the Ser518 and
Thr576 residues in the merlin protein. Phosphorylation on
Ser518 has been shown to modulate the ability of merlin to
form intramolecular associations and to bind to critical
effectors important for growth suppression [34,35]. In
contrast, phosphorylation on the Thr576 residue has no
effect on merlin's functional activity, while phosphoryla-
tion on this residue is important for the function of ERM
proteins [57,65-67]. Sequence alignment shows that the
Ser518 residue is conserved across all merlin proteins of
various species with the exception of the fruit fly and the
worm, which contain a related threonine residue at the
corresponding position (Figure 4). Since both the serine
and threonine residues can be phosphorylated, we suggest
that the corresponding threonine residue in merlin pro-
teins of the fly and the worm may act as a phosphoryla-
tion site.
Gutmann et al. showed that mutations within the pre-
dicted α-helical region of the human merlin protein had
little effect on its function, whereas those in its N- or C-ter-
minus rendered the protein inactive as a negative growth
regulator [28,29]. Specifically, five naturally occurring
missense mutations, L64P, K79E, E106G, L535P and
Q538P, were found to inactivate merlin function. Interest-
ingly, we found that the Leu64 and Lys79 residues were con-
served among the merlin and ERM proteins of various
species (Figure 4). According to the crystal structure of the
FERM domain of merlin, the L64P substitution would cre-
ate a cavity in the hydrophobic core of subdomain A and
affect its β-sheet structure [17,18]. The significance of this
structural information was further supported by the find-
ing that the L64P mutation impaired the ability of merlin
to form an intramolecular complex between its two N-ter-
minal interaction sites [28]. Moreover, the L64P mutant
lost its ability to bind the cytoplasmic tail of CD44; this
interaction correlates with the ability of merlin to func-
tion as a growth suppressor [29].BMC Evolutionary Biology 2005, 5:69 http://www.biomedcentral.com/1471-2148/5/69
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The Lys79 residue is situated at the end of helix α4A, and
mutation at this residue (K79E) may cause the formation
of a salt bridge with its neighboring Lys76 residue, which is
normally hydrogen bonded to Tyr66 in helix α3A [17].
Two equivalent lysine residues, Lys60  and Lys63, were
found in module F1 of moesin and were predicted to be
involved in specific protein interactions, consequently
changing the structure of an activated molecule [15,16].
Together with a group of positively-charged amino acids
at the beginning of the helix module F3 (R275, K278,
R279), these lysine residues interact with the negatively-
charged residues (342-REKEE-346) in the C-terminal
region [16]. Importantly, most of the homologous posi-
tively-charged residues located between lobes F1 and F3
in the radixin protein have been shown to bind to inositol
1,4,5-trisphosphate (IP3) [15]. In addition to Lys79, the
Lys76  residue was also found to be highly conserved
among various merlin and ERM proteins with the excep-
tion of the worm protein, which has a Gln76 instead of
Lys76 (Figure 4 and Additional File 1). Also, the ERM-like
proteins of parasites Taenia saginata, Echinococcus granulo-
sus, and Echinococcus multilocularis contain an Arg76 resi-
due, which is also a basic amino acid residue and may be
capable of participating in interactions similar to those of
the corresponding lysine residue. On the contrary, in the
JF2 protein of Shistosoma mansoni, the position equivalent
to Lys60 of moesin is occupied by a glutamic acid residue,
and no conservation of residues 275, 278, and 279 in the
JF2 protein was found, suggesting a unique structural fea-
ture for this Shistosoma protein.
Several other naturally-occurring missense mutations on
human merlin, including E106G, L535P and Q538P, have
also been found to affect its functional activity [29,68].
Our sequence alignment revealed that the Glu106, Leu535,
and Gln538 residues were conserved among the merlin
proteins of the Chordata group (Figure 4), highlighting
the general importance of these residues for merlin func-
tion. Similar to the L64P mutation described above, the
E106G mutation resulted in impaired intramolecular
associations of merlin [29]. However, the Leu64 residue is
highly conserved among all merlin and ERM proteins of
various species, while Glu106 is conserved only in the mer-
lin proteins of Chordata and worms. In the crystal struc-
ture of the FERM domain of merlin, the Glu106 residue is
located at the linker A-B (α1'B) and participates in the
inter-subdomain interaction by forming a hydrogen bond
with the Lys289 residue [17,18]. This interaction may ena-
ble subdomain B to rotate closer to subdomain C. Intrigu-
ingly, Lys289 is conserved only among the merlin proteins
of mammals, chickens, frogs, honeybees, and mosquitoes
(Additional File 1). In the merlin proteins of other species,
a negatively-charged aspartic or glutamic acid occupies
this position, except in fish. Instead of lysine, an arginine
residue was found in the homologous position of all ERM
proteins (e.g., Arg273 for moesin), except for the ERM-like
proteins in parasites (Additional File 1). This Arg273 resi-
due, located at the beginning of the helix of subdomain
F3, lies in a specific cleft between subdomains F1 and F3
with the positively-charged R275, K278, and R279 resi-
dues. According to the structure of radixin, the IP3-bind-
ing site is located at this basic cleft [14]. This region in the
moesin protein has also been shown to interact with its C-
terminal domain [16].
It should be mentioned that residues that are conserved in
the merlin proteins, but not in the ERM proteins, of vari-
ous species may be important for elucidating the func-
tional difference between the merlin and ERM proteins.
We found that the glutamic acid residue at position 204 of
human merlin was conserved among all merlin proteins
(Figure 3). In contrast, variable and uncharged amino
acids were found at the corresponding position of the
ERM proteins. Crystal structure of the FERM domain of
human merlin shows that the Glu204 residue lies in the
beginning of helix α4B and is included in a specific stretch
of amino acids in subdomain B [17]. By sequence align-
ment of human merlin and ERM proteins, about 70
amino acids, including this specific stretch of residues,
which are unique to merlin but different in ERM proteins,
were identified (see Additional File 1). The majority of
these amino acids can be subdivided into three clusters;
each of them is specific to its corresponding subdomain
and is located on the surface of the protein. These results
suggest that these 70 amino acids likely take part in pro-
tein-protein interactions. Note that the conserved stretch
of amino acids in subdomain B also includes the func-
tionally important "Blue Box" discussed above.
Similarly, the isoleucine residue at position 546 was
found to be conserved among the merlin proteins of vari-
ous species, while a leucine residue was present in the cor-
responding position in all ERM proteins (Figure 2). The
residue homologous to Leu529 in the C-terminal domain
of moesin is located at the end of helix A with other
hydrophobic residues, tightly contacting the hydrophobic
faces of helices B and D of subdomain F2 [15]. Although
the information about such an interaction in merlin is
presently unavailable, additional crystal structure analysis
should allow us to better understand the importance of
this amino acid residue. In addition, it will be interesting
to test whether mutations in the conserved amino acid
residues identified in this study could affect protein func-
tion.
Predicted secondary structure of merlin and comparative 
analysis of the predicted α-helical region
Turunen et al. previously reported that the central region
of ERM proteins contained approximately 200 residues
that were predicted to be mostly α-helical [19]. To exam-BMC Evolutionary Biology 2005, 5:69 http://www.biomedcentral.com/1471-2148/5/69
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The predicted secondary structures for the merlin proteins of various species Figure 5
The predicted secondary structures for the merlin proteins of various species. The region with a predicted β-sheet 
structure is shaded in grey, while the region with an α-helix structure is shaded in black. These predicted secondary structures 
correspond to the crystal structural data [18], which are shown above the alignment with the α-helix region indicated with a 
thick black bar and the β-sheet region with a thin black bar. The predicted α-helical domain in the central-to-C-terminal region 
of merlin is marked with an open bar. Asterisks denote known domains of the merlin protein with numbers pointing to the end 
of truncated Drosophila merlin protein discussed in the text. "+" denotes the beginning and the end of the predicted α-helical 
domain. The positions of specific residues in the FERM domain discussed in the text are denoted by black dots below the 
aligned sequences.BMC Evolutionary Biology 2005, 5:69 http://www.biomedcentral.com/1471-2148/5/69
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ine whether there was a similar structure present in all
merlin proteins, we analyzed 21 merlin sequences from
various organisms and predicted their secondary struc-
tures using the JPRED program [69]. The results of such an
analysis for six representative species are presented in Fig-
ure 5. The predicted locations of α-helices and β-sheets in
the N-terminal domain support the experimental findings
from the structural analysis of the FERM domain of
human merlin protein [18]. In addition, a predicted α-
helical structure in the central-to-C-terminal region was
found to be conserved among the merlin proteins of vari-
ous species analyzed. Previously, it was shown that a trun-
cated merlin protein of Drosophila, containing residues 1–
600, lost the ability to localize to the cytoplasm and was
concentrated at the plasma membrane [63]. However, two
smaller truncated proteins, consisting of residues 1–350
or 1–375, were only loosely associated with the plasma
membrane. These results suggest that the predicted α-hel-
ical region of merlin is important for its intracellular local-
ization. Since almost the entire α-helical domain was
absent in these truncated proteins, we suggest that it may
contain a determinant for membrane association. This
notion is further supported by the observation that addi-
tional truncated proteins, containing residues 1–300 or
missing almost the entire α-helical domain, were diffusely
localized to the cytoplasm.
In human merlin, the predicted α-helical structure is situ-
ated between residues K312 and K478 (Figure 5 and Addi-
tional File 1). The N-terminal border of this structure was
clearly recognized for 21 merlin sequences analyzed,
whereas the C-terminal boundary could be traced only up
to Urochordata (Ciona) and Nematoda (Caenorhabditis).
This  α-helical domain, predicted from all 21 merlin
Schematic diagram of the exon and intron structures for the merlin genes of various species Figure 6
Schematic diagram of the exon and intron structures for the merlin genes of various species. The horizontal line 
depicts the merlin gene with its size indicated in base pairs (bp) on the right. The upright boxes represent exons. The lengths 
of the merlin mRNA sequences available in the database are shown in nucleotides (nt) and the lengths of the predicted merlin 
proteins are also indicated in amino acids (aa). The indicated human NF2 mRNA refers to the longest, full-length transcript 
identified, which contains a long 3' untranslated region [72]. Two major NF2 isoforms I and II are produced via alternative splic-
ing and the lengths of their protein products are shown with that of isoform I indicated in the parentheses. It should be noted 
that Northern blot analysis detected the rat and mouse NF2 mRNAs of about 4.5 kb, indicating that the sizes of the rodent 
NF2 mRNAs shown here are not full-length. The asterisk (*) denotes the exon-intron structure of Brugia malayi predicted from 
this study.
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sequences, contains a high density of charged amino acids
(from about 25% in Ciona to greater than 40% in verte-
brates). Sequence alignment reveals 19 conserved amino
acid residues in this predicted α-helical domain (Addi-
tional File 1). The amino acid identity for the predicted α-
helical domain within each phylogenetic group is as fol-
lows: 1) Genus Drosophila (D. melanogaster and D. yakuba)
– 99% (one amino acid substitution), 2) Genus
Caenorhabditis (C. elegans, C. briggsae, and C. remanie) –
85.7%, 3) Genus Ciona (C. intestinalis and C. savignyi) –
71.7%, 4) vertebrates – 63.5%, and 5) mammals – 90%.
Taken together, these results indicate that the merlin pro-
teins of various species contain a conserved α-helical
domain in the central to C-terminal region.
Exon-intron structural evolution of the merlin gene
Recent progress in automated computational analysis of
partially and completely sequenced genomes using a gene
prediction method and the analysis of expressed sequence
tag (EST) has provided considerable opportunities not
only to describe novel genes but also their exon-intron
structures. Such an approach also allows the examination
of the presence of different splicing variants/isoforms. To
understand the evolution of the exon-intron structure of
the merlin gene, we assembled all available NF2 gene-
related sequences from various taxa. Using the sequences
of proteins, mRNAs, and combined contigs [70], we estab-
lished the structure of the merlin-like gene for Brugia
malayi, which consists of 12 exons and 11 introns (Figure
6). Analogously, the homolog of the NF2  gene in
Caenorhabditis elegans was found to contain 11 exons and
10 introns. It should be mentioned that the two NF2-like
sequences, nfm-1a and nfm-1b of Caenorhabditis elegans,
differ from each other only by the sequence of the last
exon (Additional File 1), suggesting that they represent
cDNA isoforms.
As shown in Figure 6, the general arrangement of the mer-
lin gene structure is conserved among mammalian spe-
cies, especially at the region that encodes the N-terminal
domain, albeit the length of the genes may differ slightly.
The human NF2  gene consists of 17 exons and spans
about 95 kb of DNA [5,6,71,72]. NF2 transcripts undergo
alternative splicing, generating multiple isoforms [72-79].
Isoform I, missing exon 16, and isoform II, containing all
17 exons, are the two predominant species. As the result
of alternative splicing, isoform 1 encodes a 595 amino
acid protein. Isoform II differs from isoform I only at the
C-terminus. Insertion of exon 16 into the mRNA provides
a new stop codon, resulting in a 590 amino acid protein
that is identical to isoform I over the first 579 residues.
Because of the presence of a long 3' untranslated region,
the longest NF2 isoform I RNA, containing the sequence
from all 17 exons, is about 6.1 kb [72]. The merlin genes
of other mammalian species, Rattus norvegicus,  Canis
familiaris, Mus musculus and Pan troglodytes, contain 16
exons (Figures 6 and 7). In addition, alternatively spliced
merlin isoforms have been found in rodent species [80-
82]. On the contrary, the structure of the merlin genes of
Gallus gallus and  Fugu rubripes are arranged differently
from those of mammalian species, with 15 and 14 exons
spanning much shorter DNAs of only about 25 kb and
12.3 kb, respectively (Figure 6). Although the NF2 gene of
Fugu rubripes has not yet been completely assembled, we
The alignment of exons with specific domains of merlin reveals the presence of homologous introns Figure 7
The alignment of exons with specific domains of merlin reveals the presence of homologous introns. Boxes rep-
resent the coding exons with numbers indicated accordingly. The locations of the three commonly discussed domains are 
marked with horizontal arrows under exons. The boundaries among these domains were defined according to the human mer-
lin protein. The asterisk indicates that the exon structure shown is common to the merlin genes of all vertebrate species stud-
ied, including Homo sapiens, Pan troglodytes, Canis familaris, Mus musculus, Rattus norvegicus, Danio rerio, Fugu rubripes, and 
Xenopus laevis. The overall merlin gene structure of Gallus gallus is similar, except that exons 15 and 16 are fused together in 
this species.BMC Evolutionary Biology 2005, 5:69 http://www.biomedcentral.com/1471-2148/5/69
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predict that it lacks the sequences of the first and the last
exons of the mammalian NF2 gene based on our sequence
alignment (see Additional File 1).
In spite of the presence of 16 exons and the size of tran-
script similar to those found in some vertebrates, the gene
for the merlin-like protein of Ciona intestinalis is relatively
small with only about 4.3 kb (Figure 6). This tendency
towards reduction of intron length and number continues
to be seen in the merlin gene of worms and insects (Fig-
ures 6 and 7). The gene for the merlin-like protein of
Caenorhabditis elegans, consisting of 11 exons, spans about
4.7-kb DNA, and that of Brugia malayi, containing 12
exons, is about 5.5 kb in length. The NF2 homolog of Dro-
sophila melanogaster and the gene for the merlin-like pro-
tein of Apis mellifera are only about 2.9 kb, the smallest in
the merlin clade, and consist of 5 and 8 exons, respectively
(Figure 6). Interestingly, some conservation of the posi-
tions of homologous introns can be found in the NF2
gene from various species (Figure 7); however, the sizes of
their introns are variable. Such an evolutionary conserva-
tion of homologous introns implies that the presence of
regulatory sequences in the introns to regulate the tran-
scriptional event.
Unlike the sizes and structures of the merlin or merlin-like
genes in various organisms, the lengths of the merlin pro-
teins and transcripts have not changed very much during
evolution (Figure 6). Moreover, several functionally
important domains of merlin also remain conserved.
Since the merlin protein of the insect emerged after devi-
ation from that of the worm, which was anciently derived
from the common ancestor (Figure 1), it appears that the
decrease in gene size and exon number occurred specifi-
cally within the insect group. This branch of merlin evolu-
tion is likely to develop independently and in the
opposite direction from those more recently developed
merlin proteins of Chordata. Parallel evolution towards
the increase in merlin gene size and exon number
between the worm and Chordata appears to be less likely.
Thus, it is possible that the common ancestor for the mer-
lin genes of the worm, the insect, and Chordata may con-
tain a few more exons. During evolution, reduction of
introns and/or fusion of exons occur within the insect
group.
It is evident that the genome of the insect is more compli-
cated than that of the worm. The simplification of the
merlin gene structure in the insect is unique and may have
a functional significance. This observation may explain
the lack of splicing variants of the NF2 homolog in Dro-
sophila, in contrast to those merlin isoforms found in
mammals [72-82] and in Caenorhabditis elegans as we pre-
dicted in this study.
Conclusion
We have conducted the phylogenetic analysis of merlin
diversity across metazoan genomes using the experimen-
tally annotated and predicted sequences in conjunction
with bioinformatic tools. We show that the merlin pro-
teins have a monophyletic origin with a root in the early
metazoa. We have also established the expansion of the
ERM-like ancestors within the vertebrate clade that
occurred after its separation from Urochordata. Several
potentially important sites that are conserved among all
merlin proteins but are divergent in the ERM members
have been identified. As supported by the crystal structure
data, these conserved residues are likely to be important
for merlin function. Analysis of the evolution of the mer-
lin gene structure reveals the existence of common splic-
ing variants in human and Caenorhabditis elegans. While a
trend toward the increase of gene length during evolution
was observed, a reduction of intron number and length
appears to occur in the merlin gene of the insect group.
Taken together, our results have important implications
for the evolution of the merlin proteins and their possible
functional variability in different taxa.
Methods
BLAST search
Initial sequences of genes and proteins of interest from
various organisms were identified from the National
Center for Biotechnology Information (NCBI) database
[83] using the BLAST algorithm [84]. We then searched
the desirable sequences across genomic databases of com-
pletely or partially sequenced genomes available at The
Sanger Institute [85] and The Institute for Genomic
Research (TIGR; [86]). Also, we investigated other availa-
ble sequence databases that contain information for spe-
cific organisms. The sources of sequences of the predicted
or experimentally annotated merlin and ERM proteins are
summarized in Table 1.
To obtain the entire amino acid sequence of an annotated
protein, we used UniProt from Universal Protein Resource
[87]. The erythrocyte membrane proteins 4.1 sequences of
Homo sapiens (GenBank: CAI21970), Mus musculus (Gen-
Bank: NP_001006665), and Danio rerio (GenBank:
AAQ97985) were also included in the analysis as an out-
group. Because of the presence of many non-conserved
and large introns in the genes of interest, we conducted
BLAST search using TBLASTN alignment algorithm in the
cases where no protein sequences were available.
Alignments and phylogeny
The CLUSTAL_X program [88] was used to align the char-
acterized or predicted protein sequences from different
species. Phylogenetic analysis was carried out using the
MEGA2.1 program [49].BMC Evolutionary Biology 2005, 5:69 http://www.biomedcentral.com/1471-2148/5/69
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Secondary structure prediction
The secondary structure prediction program JPRED [69]
was used to predict the secondary structure of each merlin
protein from various species. This program uses physical-
chemical properties of the amino acid sequence and neu-
ral network for recognition of α-helices and β-sheets.
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